Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Choosing the Right CDMO for CGT Programs: Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products
In: Pharmaceutical Technology, Jg. 46 (2022-10-01), Heft 10, S. 60-63
Online
serialPeriodical
Zugriff:
Titel: |
Choosing the Right CDMO for CGT Programs: Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products
|
---|---|
Autor/in / Beteiligte Person: | Mullan, Brian |
Link: | |
Zeitschrift: | Pharmaceutical Technology, Jg. 46 (2022-10-01), Heft 10, S. 60-63 |
Veröffentlichung: | 2022 |
Medientyp: | serialPeriodical |
ISSN: | 1543-2521 (print) |
Sonstiges: |
|